Toward the first nose drops to treat brain cancer

September 22, 2010

Scientists are reporting the development and successful initial testing of a new form of methotrexate -- the mainstay anticancer drug -- designed to be given as nose drops rather than injected. It shows promise as a more effective treatment for brain cancer, they say. The report appears in ACS' Molecular Pharmaceutics journal.

Tomotaka Shingaki and colleagues note that brain cancer is difficult to treat, partly because current anticancer drugs have difficulty reaching the brain. That's because the so-called blood-brain barrier (a protective layer of cells surrounding the brain) prevents medication in the blood from entering the brain. But new evidence indicates that some drugs administered through the nose, either as nose drops or nasal spray, can bypass this barrier and travel directly into the brain. Among them are drugs for migraine headaches. Until now, however, nobody knew if methotrexate might do the same.

The scientists tested methotrexate nose drops on laboratory rats with . Compared to cancer treated with an injectable form of the drug, the nose drop drug reduced the weight of tumors by almost one-third, the scientists said. "The strategy to utilize the nose-brain direct transport can be applicable to a new therapeutic system not only for but also for other disorders such as ," the article noted.

More information: "Transnasal delivery of methotrexate to brain tumors in rats: A new strategy for brain tumor chemotherapy", Molecular Pharmaceutics.

Related Stories

Recommended for you

Bioelectricity new weapon to fight dangerous infection

May 26, 2017

Changing the natural electrical signaling that exists in cells outside the nervous system can improve resistance to life-threatening bacterial infections, according to new research from Tufts University biologists. The researchers ...

New hair growth mechanism discovered

May 25, 2017

In experiments in mice, UC San Francisco researchers have discovered that regulatory T cells (Tregs; pronounced "tee-regs"), a type of immune cell generally associated with controlling inflammation, directly trigger stem ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.